Callum Smith lashed out at his critics after breathing new life into his faltering career by out-slugging Joshua Buatsi in a fire-fight. Former super-middleweight world champion Smith had ...
Joshua Buatsi is determined to defeat Callum Smith to secure a shot at the Artur Beterbiev vs Dmitry Bivol winner. Beterbiev rematches Bivol for the undisputed light-heavyweight world championship ...
To that end, Florida Tech has relaunched the underutilized Center for Advanced Manufacturing and Innovative Design as Vertex, a new "applied innovation hub." Rather than function as a traditional ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...
AlgoTx’s mid-stage stumble on Tuesday comes after Vertex earlier this month won the FDA’s approval for Journavx, an inhibitor of the NaV1.8 voltage-gated sodium channel that marks the first new ...
Anthony Joshua's quest to become a three-time world champion appears to have resumed with the Brit having begun training for the first time since his comprehensive loss to his compatriot last year.
Fresh off of winning a gold medal at the London 2012 Olympics, 18-year-old Anthony Joshua signed with Eddie Hearn's Matchroom Boxing promotion before his first professional fight. The rest is history.
SINGAPORE – Two Nominated Members of Parliament – lawyer Raj Joshua Thomas and psychiatrist Syed Harun Alhabsyi – resigned on Feb 14, the first time any NMP has done so before the end of his ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.
Former heavyweight star David Price has backed two-time champion Anthony Joshua to win another version of a world title. 'AJ' is at a crossroads at the moment in terms of what's next. The 35-year ...
Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results